HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong-Tai Chang Selected Research

Tamoxifen

1/2018Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients.
6/2016Association between tamoxifen treatment and the development of different stages of nonalcoholic fatty liver disease among breast cancer patients.
3/2003The anti-breast cancer drug tamoxifen alters Ca2+ movement in Chinese hamster ovary (CHO-K1) cells.
7/2002Effect of the anti-breast cancer drug tamoxifen on Ca(2+) movement in human osteosarcoma cells.
1/2002Tamoxifen-induced increases in cytoplasmic free Ca2+ levels in human breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong-Tai Chang Research Topics

Disease

31Breast Neoplasms (Breast Cancer)
03/2024 - 01/2002
23Osteosarcoma (Osteogenic Sarcoma)
10/2016 - 03/2002
19Neoplasms (Cancer)
08/2018 - 12/2003
19Prostatic Neoplasms (Prostate Cancer)
02/2017 - 02/2002
4Carcinogenesis
03/2024 - 01/2012
4Stomach Neoplasms (Stomach Cancer)
10/2019 - 12/2013
4Neoplasm Metastasis (Metastasis)
11/2018 - 03/2016
4Hepatocellular Carcinoma (Hepatoma)
11/2016 - 01/2009
4Mouth Neoplasms (Oral Cancer)
01/2016 - 07/2005
2Stroke (Strokes)
01/2021 - 11/2017
2Lung Neoplasms (Lung Cancer)
06/2018 - 03/2016
2Fatty Liver
01/2018 - 06/2016
2Triple Negative Breast Neoplasms
01/2018 - 12/2017
2Fibrosis (Cirrhosis)
01/2018 - 09/2017
2Infections
01/2018 - 12/2011
2Glioblastoma (Glioblastoma Multiforme)
09/2014 - 11/2011
2Sepsis (Septicemia)
02/2013 - 01/2011
2Neuroblastoma
07/2004 - 03/2002
2Urinary Bladder Neoplasms (Bladder Cancer)
03/2002 - 01/2002
1Central Nervous System Diseases (CNS Diseases)
01/2020
1Breast Ductal Carcinoma
08/2018
1Non-alcoholic Fatty Liver Disease
01/2018
1Pathologic Complete Response
12/2017
1Chronic Kidney Failure (Chronic Renal Failure)
11/2017
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2017
1Hypertension (High Blood Pressure)
11/2017
1Myocardial Infarction
11/2017
1Heart Failure
11/2017
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
11/2017
1Chronic Obstructive Pulmonary Disease (COPD)
11/2017
1Dyslipidemias (Dyslipidemia)
11/2017
1Cholelithiasis
09/2017
1Cholecystitis
09/2017
1Gallstones (Gallstone)
09/2017
1Mood Disorders (Mood Disorder)
10/2016

Drug/Important Bio-Agent (IBA)

21Fura-2 (Fura 2)IBA
10/2012 - 01/2002
9Type C PhospholipasesIBA
10/2013 - 03/2002
8Biomarkers (Surrogate Marker)IBA
03/2024 - 03/2014
7MicroRNAs (MicroRNA)IBA
06/2018 - 01/2012
6Antidepressive Agents (Antidepressants)IBA
06/2015 - 12/2003
6Fluorescent Dyes (Fluorescent Probes)IBA
10/2012 - 07/2004
5TamoxifenFDA LinkGeneric
01/2018 - 01/2002
4Protein Kinase CIBA
11/2011 - 02/2003
3EnzymesIBA
03/2024 - 09/2015
3ThymolIBA
02/2017 - 01/2011
3Protriptyline (Vivactil)FDA LinkGeneric
11/2016 - 01/2015
3Mitogen-Activated Protein KinasesIBA
01/2012 - 02/2007
3Indicators and Reagents (Reagents)IBA
01/2006 - 01/2002
3Coloring Agents (Dyes)IBA
01/2006 - 02/2003
2ErbB Receptors (EGF Receptor)IBA
03/2024 - 01/2020
2Hormones (Hormone)IBA
01/2020 - 03/2005
2DNA (Deoxyribonucleic Acid)IBA
10/2019 - 09/2015
2Small Interfering RNA (siRNA)IBA
01/2018 - 10/2013
2Proteins (Proteins, Gene)FDA Link
01/2018 - 10/2013
2CateninsIBA
12/2017 - 03/2016
2cyclic 3',5'-thymidine monophosphate (cTMP)IBA
05/2017 - 10/2013
2Miconazole (Monistat)FDA LinkGeneric
12/2015 - 03/2005
2NPC 14686IBA
10/2015 - 01/2006
25-hydroxymethylcytosineIBA
09/2015 - 08/2015
2Estrogens (Estrogen)FDA Link
10/2013 - 12/2003
2CarcinogensIBA
06/2011 - 07/2005
2ThapsigarginIBA
06/2011 - 12/2003
2calmidazoliumIBA
01/2009 - 10/2004
2Desipramine (Pertofrane)FDA LinkGeneric
08/2008 - 12/2003
2anandamide (arachidonylethanolamide)IBA
06/2008 - 02/2007
2capsazepineIBA
08/2006 - 10/2004
2Safrole (Safrol)IBA
08/2006 - 07/2005
2Masoprocol (Actinex)FDA Link
09/2004 - 03/2002
2Maprotiline (Ludiomil)FDA Link
07/2004 - 07/2004
2triethyltinIBA
06/2003 - 02/2002
23- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA
09/2002 - 03/2002
1Progesterone Receptors (Progesterone Receptor)IBA
03/2024
1keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA
01/2020
1globo H-KLH vaccineIBA
01/2020
1neratinibIBA
01/2020
1Globo-HIBA
01/2020
1EpitopesIBA
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1Lapatinib (GW572016)FDA Link
01/2020
1Loperamide (Imodium)FDA LinkGeneric
01/2020
1Capecitabine (Xeloda)FDA Link
01/2020
1Long Noncoding RNAIBA
10/2019
1extracellular matrix receptorIBA
08/2018
1InterferonsIBA
01/2018
1Phosphotransferases (Kinase)IBA
01/2018
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Adenosine Triphosphate (ATP)IBA
01/2018
1Dipeptidyl-Peptidase IV InhibitorsIBA
11/2017
1Trastuzumab (Herceptin)FDA Link
05/2017
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
10/2016
1Cytochalasin BIBA
08/2016
1Ellagic AcidIBA
06/2016
1Estrogen ReceptorsIBA
06/2016

Therapy/Procedure

12Therapeutics
11/2018 - 01/2012
4Drug Therapy (Chemotherapy)
11/2018 - 05/2007
1Subacute Care
01/2021
1Percutaneous Coronary Intervention
11/2017
1Cholecystectomy
09/2017
1Gastrectomy
09/2017